| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Vedolizumab and Anti-Vedo
Test CodeVEDO
CPT Codes
80299, 82397
Preferred Specimen
3 mL serum
Minimum Volume
1 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) tube
Instructions
Allow a minimum clotting time of 30 to 60 minutes with serum separation within 2 hours of collection. Send serum in a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Transport Temperature
Frozen
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 14 days
Refrigerated: 14 days
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Gross lipemia
Methodology
Electrochemiluminescent Immunoassay
Setup Schedule
Wed
Report Available
6-8 days
Reference Range
Vedolizumab (01)
Quantitation Limit: <1.5 ug/mL
Results of 1.5 or higher indicate detection of Vedolizumab
Anti-Vedolizumab (01)
Quantitation Limit: <25 ng/mL
Results of 25 or higher indicate detection of antivedolizumab antibodies
Quantitation Limit: <1.5 ug/mL
Results of 1.5 or higher indicate detection of Vedolizumab
Anti-Vedolizumab (01)
Quantitation Limit: <25 ng/mL
Results of 25 or higher indicate detection of antivedolizumab antibodies
Clinical Significance
Provides serum concentrations of vedolizumab and anti-vedolizumab antibodies in order to optimize treatment and facilitate clinical decision making.
Performing Laboratory
Esoterix Endocrinology
4301 Lost Hills Road
Calabasas Hills, CA 91301
